drugset / Trial / NCT00813046
Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the oral administration of grass pollen peptides to treat allergic rhinitis is safe and well tolerated.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | gpASIT+TM | Peptide | 25 ug | Oral |
| Subject | gpASIT+TM | Peptide | 1600 ug | Oral |